Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale

Fig. 1

The course, evolution, medication, and events of tigecycline-related DILI. The events of resumption of tacrolimus and reduction of tigecycline dose on day 11 of LICU admission were indicated by ; The event of liver puncture biopsy on day 12 of LICU admission was indicated by ; The event of administration of methylprednisolone on day 13 of LICU admission was indicated by . Abbreviation: TB, total bilirubin; ALT, alanine aminotransferase; ALP, alkaline phosphatase; PMB, polymyxin B; MEM, meropenem; TGC, tigecycline; CAZ-AVI, ceftazidime/avibactam; DILI, drug-induced liver injury

Back to article page